# 18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy

> **NCT07724535** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 30 (estimated)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** 18F-grazy-02

## Key facts

- **NCT ID:** NCT07724535
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-24
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07724535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07724535, "18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07724535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*